ADMA Biologics Sponsored Study Titled 'An Open Label, Multicenter Study to Evaluate the Pharmacokinetics, Efficacy and Safety of ASCENIV (IGIV) in Pediatric Subjects With Primary Immunodeficiency Diseases (PIDD)' Posted To ClinicalTrials.gov